Belluscura Plc
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Market Cap & Net Worth: Belluscura Plc (BELL)
Belluscura Plc (LSE:BELL) has a market capitalization of $36.62K (GBX300.98 Million) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #49202 globally and #1317 in its home market, demonstrating a 3.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Belluscura Plc's stock price GBX0.75 by its total outstanding shares 401309607 (401.31 Million).
Belluscura Plc Market Cap History: 2021 to 2025
Belluscura Plc's market capitalization history from 2021 to 2025. Data shows change from $5.47 Million to $36.62K (-64.64% CAGR).
Index Memberships
Belluscura Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$41.09 Million | 0.00% | #342 of 722 |
Weight: Belluscura Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Belluscura Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Belluscura Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.36x
Belluscura Plc's market cap is 1.36 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $5.47 Million | $420.32K | -$5.03 Million | 13.01x | N/A |
| 2022 | $3.20 Million | $1.40 Million | -$8.76 Million | 2.29x | N/A |
| 2023 | $1.12 Million | $825.41K | -$18.52 Million | 1.36x | N/A |
Competitor Companies of BELL by Market Capitalization
Companies near Belluscura Plc in the global market cap rankings as of March 19, 2026.
Key companies related to Belluscura Plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Belluscura Plc Historical Marketcap From 2021 to 2025
Between 2021 and today, Belluscura Plc's market cap moved from $5.47 Million to $ 36.62K, with a yearly change of -64.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | GBX36.62K | -91.89% |
| 2024 | GBX451.66K | -59.78% |
| 2023 | GBX1.12 Million | -64.89% |
| 2022 | GBX3.20 Million | -41.52% |
| 2021 | GBX5.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Belluscura Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.62K USD |
| MoneyControl | $36.62K USD |
| MarketWatch | $36.62K USD |
| marketcap.company | $36.62K USD |
| Reuters | $36.62K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.